Yuanyuan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuanyuan Liu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Chongbin Wei
ITI Medical Equipment Co., Ltd., Changzhou 213161, China
1 shared publication - Dacheng Sang
Peking University Third Hospital
1 shared publication - Feifei Zhou
Peking University Third Hospital
1 shared publication - Yuling Zhang
Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Guangzhou, China
1 shared publication - Zhaojun Jia
Department of Pharmaceutical Engineering, School of Biomedicine and Health Sciences Beijing Institute of Petrochemical Technology Beijing Beijing China
1 shared publication
Latest Publications
- Open Access
- 22 January 2026
- Published by Scilight Press Pty Ltd in Regenerative Medicine and Dentistry
- Vol. 3 (1) , 1
From Biomimetic to Bioadaptive: Next-Generation Titanium Implants for Functional Bone Regeneration
Titanium-based implants are predominantly adopted in orthopedic and dental applications, yet their clinical performance is constrained by enduring challenges such as stress shielding, infection susceptibility, and inadequate osseointegration. To address these hurdles, recent advances have shifted titanium implant design from static biomimetic models toward dynamic, bioadaptive systems capable of actively modifying their architectural, mechanical, and surface properties after implantation. These systems can respond adaptively to specific pathophysiological microenvironments or be activated by external energy sources (e.g., light, ultrasound, electricity, or magnetism), thus providing on-demand biofunctionalities, such as antibacterial, pro-angiogenic, osteogenic, and immune/metabolic regulatory effects, ultimately mitigating complications (e.g., infection, inflammation) while accelerating osteoregeneration and osteointegration. In this Perspective, we propose a strategic framework to guide the design and development of next-generation titanium implants aligned with this trend. It highlights the emerging need to converge a deeper understanding of implant-biology interplays with synergistic advances from materials science (e.g., metamaterial and stimuli-responsive interface design) and cutting-edge bone biology (e.g., immunometabolic and neuro-osseous engineering). This interdisciplinary integration is aimed at enabling expedited, robust, bioadaptive regeneration regimens, particularly for challenging bone defects such as infected, osteoporotic, or diabetic conditions.
- 22 January 2026
- Published by Scilight Press Pty Ltd in Regenerative Medicine and Dentistry
- Vol. 3 (1) , 1
Open AccessFrom Biomimetic to Bioadaptive: Next-Generation Titanium Implants for Functional Bone Regeneration
Titanium-based implants are predominantly adopted in orthopedic and dental applications, yet their clinical performance is constrained by enduring challenges such as stress shielding, infection susceptibility, and inadequate osseointegration. To address these hurdles, recent advances have shifted titanium implant design from static biomimetic models toward dynamic, bioadaptive systems capable of actively modifying their architectural, mechanical, and surface properties after implantation. These systems can respond adaptively to specific pathophysiological microenvironments or be activated by external energy sources (e.g., light, ultrasound, electricity, or magnetism), thus providing on-demand biofunctionalities, such as antibacterial, pro-angiogenic, osteogenic, and immune/metabolic regulatory effects, ultimately mitigating complications (e.g., infection, inflammation) while accelerating osteoregeneration and osteointegration. In this Perspective, we propose a strategic framework to guide the design and development of next-generation titanium implants aligned with this trend. It highlights the emerging need to converge a deeper understanding of implant-biology interplays with synergistic advances from materials science (e.g., metamaterial and stimuli-responsive interface design) and cutting-edge bone biology (e.g., immunometabolic and neuro-osseous engineering). This interdisciplinary integration is aimed at enabling expedited, robust, bioadaptive regeneration regimens, particularly for challenging bone defects such as infected, osteoporotic, or diabetic conditions.